Omnipaque-350 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: iohexol
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 15.1g/20mL injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear, colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 20 mLx10 pack
- 20mLx25 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 37.75g/50mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 50 mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 56.625g/75mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 16 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 75mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 151g/200mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 200 mLx10 pack
- 200mL x 6 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 151g/200mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 200 mLx10 pack
- 200mL x 6 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 113.25g/150mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intraarterial
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 30 Months.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 150 mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 75.5g/100mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 2 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 100 mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 94.375g/125mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 125 mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 132.125g/175mL injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow slightly viscous liquid
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 175 mLx10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: OMNIPAQUE 350 iohexol 377.5 g/500 mL solution for injection bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
The medicinal product is for diagnostic use only Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography.,Oral/body cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), hemiography, hysterosalpingography, and in adults, children and premature babies for studies of the gastrointestinal tract.,Intrathecal: ONMIPAQUE is indicated for lumbar, thoracic, cervical and total columnar myelography and in computerised tomography of the CNS in adults and children.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intraarterial
- a clear, colourless to pale yellow, sterile aqueous solution
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 6 bottles pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems